Toronto Dominion Bank’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-552
| Closed | – | – | 1440 |
|
|
2020
Q1 | $0 | Buy |
552
+399
| +261% | +$144 | ﹤0.01% | 1555 |
|
|
2019
Q4 | $0 | Buy |
+153
| New | +$254 | ﹤0.01% | 1628 |
|
|
2019
Q3 | – | Sell |
-116
| Closed | – | – | 1765 |
|
|
2019
Q2 | $0 | Buy |
116
+97
| +511% | +$248 | ﹤0.01% | 1872 |
|
|
2019
Q1 | $0 | Sell |
19
-32
| -63% | -$104 | ﹤0.01% | 1823 |
|
|
2018
Q4 | $0 | Buy |
+51
| New | +$170 | ﹤0.01% | 1727 |
|
|
2018
Q2 | – | Sell |
-9
| Closed | – | – | 1620 |
|
|
2018
Q1 | $0 | Buy |
+9
| New | +$14 | ﹤0.01% | 1478 |
|
|
2017
Q4 | – | Sell |
-84
| Closed | – | – | 1346 |
|
|
2017
Q3 | $0 | Buy |
+84
| New | +$286 | ﹤0.01% | 1285 |
|
|
2017
Q1 | – | Sell |
-95
| Closed | – | – | 1319 |
|
|
2016
Q4 | $0 | Buy |
+95
| New | +$272 | ﹤0.01% | 1349 |
|
|
2016
Q1 | – | Sell |
-49
| Closed | – | – | 1324 |
|
|
2015
Q4 | $0 | Buy |
+49
| New | +$409 | ﹤0.01% | 1129 |
|
|
2015
Q3 | – | Sell |
-20
| Closed | – | – | 1147 |
|
|
2015
Q2 | $0 | Sell |
20
-23
| -53% | -$214 | ﹤0.01% | 1167 |
|
|
2015
Q1 | $0 | Buy |
+43
| New | +$412 | ﹤0.01% | 1118 |
|
|
2014
Q3 | – | Sell |
-36
| Closed | – | – | 1081 |
|
|
2014
Q2 | $0 | Hold |
36
| – | – | ﹤0.01% | 1105 |
|
|
2014
Q1 | $0 | Hold |
36
| – | – | ﹤0.01% | 1094 |
|
|
2013
Q4 | $0 | Hold |
36
| – | – | ﹤0.01% | 1067 |
|
|
2013
Q3 | $0 | Hold |
36
| – | – | ﹤0.01% | 836 |
|
|
2013
Q2 | $0 | Buy |
+36
| New | +$72 | ﹤0.01% | 803 |
|
Toronto Dominion Bank's CORV Position: Q2 2020 in Review
Toronto Dominion Bank sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 552 shares.
Toronto Dominion Bank first reported a position in CORV in Q2 2013 and held it in 16 quarters. The position peaked at $0 in Q1 2020. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.
- Toronto Dominion Bank reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
- Toronto Dominion Bank sold 552 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020.
- Toronto Dominion Bank first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 16 quarters.
- Toronto Dominion Bank's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $0 in Q1 2020.
- 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.
Based on Toronto Dominion Bank's 13F filing for Q2 2020, filed 7 Aug 2020.